Published in J Mol Biol on February 23, 2011
Complement System Part I - Molecular Mechanisms of Activation and Regulation. Front Immunol (2015) 1.52
Complement System Part II: Role in Immunity. Front Immunol (2015) 1.31
How apoptotic cells aid in the removal of their own cold dead bodies. Cell Death Differ (2012) 1.29
The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity. Nat Immunol (2013) 1.29
Calreticulin in the immune system: ins and outs. Trends Immunol (2012) 1.23
Complement, c1q, and c1q-related molecules regulate macrophage polarization. Front Immunol (2014) 1.06
X-ray structure of the human calreticulin globular domain reveals a peptide-binding area and suggests a multi-molecular mechanism. PLoS One (2011) 1.02
Emerging and Novel Functions of Complement Protein C1q. Front Immunol (2015) 0.99
The C1q family of proteins: insights into the emerging non-traditional functions. Front Immunol (2012) 0.95
The human c1q globular domain: structure and recognition of non-immune self ligands. Front Immunol (2012) 0.91
Mechanisms of Translocation of ER Chaperones to the Cell Surface and Immunomodulatory Roles in Cancer and Autoimmunity. Front Oncol (2015) 0.90
Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination. Acta Neuropathol Commun (2013) 0.90
Human and pneumococcal cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) proteins are both ligands of human C1q protein. J Biol Chem (2012) 0.88
Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity. Front Immunol (2014) 0.86
The ever-expanding immunomodulatory role of calreticulin in cancer immunity. Front Oncol (2015) 0.83
The influence of natural lipid asymmetry upon the conformation of a membrane-inserted protein (perfringolysin O). J Biol Chem (2014) 0.81
Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity. Immunol Rev (2016) 0.78
The C-Terminal Acidic Region of Calreticulin Mediates Phosphatidylserine Binding and Apoptotic Cell Phagocytosis. J Immunol (2016) 0.76
Structural and Functional Characterization of a Single-Chain Form of the Recognition Domain of Complement Protein C1q. Front Immunol (2016) 0.75
Fundamental role of C1q in autoimmunity and inflammation. Immunol Res (2015) 0.75
In silico and in vitro studies on the protein-protein interactions between Brugia malayi immunomodulatory protein calreticulin and human C1q. PLoS One (2014) 0.75
Calreticulin is an effective immunologic adjuvant to tumor-associated antigens. Exp Ther Med (2017) 0.75
The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J Biol Chem (2003) 2.02
C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol (2004) 1.98
Structure and activation of the C1 complex of complement: unraveling the puzzle. Trends Immunol (2004) 1.59
C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition. J Immunol (2008) 1.59
Structural insights into the innate immune recognition specificities of L- and H-ficolins. EMBO J (2007) 1.53
X-ray structure of the Ca2+-binding interaction domain of C1s. Insights into the assembly of the C1 complex of complement. J Biol Chem (2003) 1.21
Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins. J Immunol (2005) 1.19
Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin. J Biol Chem (2009) 1.16
Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation. Mol Immunol (2009) 1.14
Identification of the C1q-binding Sites of Human C1r and C1s: a refined three-dimensional model of the C1 complex of complement. J Biol Chem (2009) 1.13
Molecular organization of human Ficolin-2. Mol Immunol (2006) 1.11
Interaction of C1q and mannan-binding lectin with viruses. Immunobiology (2002) 1.09
Modified low density lipoproteins differentially bind and activate the C1 complex of complement. Mol Immunol (2006) 1.08
A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. J Biol Chem (2010) 1.08
Crystal structure of the CUB1-EGF-CUB2 domain of human MASP-1/3 and identification of its interaction sites with mannan-binding lectin and ficolins. J Biol Chem (2008) 1.08
Complement protein C1q induces maturation of human dendritic cells. Mol Immunol (2007) 1.06
Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J Immunol (2006) 1.05
Structural basis for innate immune sensing by M-ficolin and its control by a pH-dependent conformational switch. J Biol Chem (2007) 1.04
Epstein-Barr virus in systemic autoimmune diseases. Clin Dev Immunol (2013) 1.04
X-ray structure of the human calreticulin globular domain reveals a peptide-binding area and suggests a multi-molecular mechanism. PLoS One (2011) 1.02
BCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex. Virology (2008) 1.01
Studies on the interactions between C-reactive protein and complement proteins. Immunology (2007) 1.01
The two major oligomeric forms of human mannan-binding lectin: chemical characterization, carbohydrate-binding properties, and interaction with MBL-associated serine proteases. J Immunol (2005) 1.00
Identification of the site of human mannan-binding lectin involved in the interaction with its partner serine proteases: the essential role of Lys55. J Immunol (2007) 0.99
How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases? Curr Opin Rheumatol (2016) 0.99
Monomeric structures of the zymogen and active catalytic domain of complement protease c1r: further insights into the c1 activation mechanism. Structure (2002) 0.98
Characterization of recombinant mannan-binding lectin-associated serine protease (MASP)-3 suggests an activation mechanism different from that of MASP-1 and MASP-2. J Immunol (2004) 0.98
Peptide binding specificity of the chaperone calreticulin. Biochim Biophys Acta (2007) 0.97
Efficacy and compatibility with mass spectrometry of methods for elution of proteins from sodium dodecyl sulfate-polyacrylamide gels and polyvinyldifluoride membranes. Anal Biochem (2004) 0.97
M-ficolin interacts with the long pentraxin PTX3: a novel case of cross-talk between soluble pattern-recognition molecules. J Immunol (2011) 0.96
CrossWork: software-assisted identification of cross-linked peptides. J Proteomics (2011) 0.95
Epstein-Barr virus and systemic lupus erythematosus. Clin Dev Immunol (2012) 0.95
Mapping surface accessibility of the C1r/C1s tetramer by chemical modification and mass spectrometry provides new insights into assembly of the human C1 complex. J Biol Chem (2010) 0.94
Cutting edge: C1q binds deoxyribose and heparan sulfate through neighboring sites of its recognition domain. J Immunol (2010) 0.94
Expression of recombinant human complement C1q allows identification of the C1r/C1s-binding sites. Proc Natl Acad Sci U S A (2013) 0.94
Deciphering complement mechanisms: the contributions of structural biology. Mol Immunol (2007) 0.93
Assembly of C1 and the MBL- and ficolin-MASP complexes: structural insights. Immunobiology (2006) 0.93
The X-ray structure of human mannan-binding lectin-associated protein 19 (MAp19) and its interaction site with mannan-binding lectin and L-ficolin. J Biol Chem (2004) 0.93
Structural insights into the recognition properties of human ficolins. J Innate Immun (2009) 0.92
The human c1q globular domain: structure and recognition of non-immune self ligands. Front Immunol (2012) 0.91
Structural biology of the C1 complex of complement unveils the mechanisms of its activation and proteolytic activity. Mol Immunol (2002) 0.91
Complement protein C1q recognizes a conformationally modified form of the prion protein. Biochemistry (2005) 0.91
Sargassum fusiforme fraction is a potent and specific inhibitor of HIV-1 fusion and reverse transcriptase. Virol J (2008) 0.91
Dimerization and oligomerization of the chaperone calreticulin. Eur J Biochem (2003) 0.90
Relative contribution of c1q and apoptotic cell-surface calreticulin to macrophage phagocytosis. J Innate Immun (2014) 0.90
Structural and functional characterization of the recombinant human mitochondrial trifunctional protein. Biochemistry (2010) 0.90
How phagocytes track down and respond to apoptotic cells. Crit Rev Immunol (2009) 0.90
Characterization of the interaction between L-ficolin/p35 and mannan-binding lectin-associated serine proteases-1 and -2. J Immunol (2002) 0.89
Mannose-binding lectin (MBL) substitution: recovery of opsonic function in vivo lags behind MBL serum levels. J Immunol (2009) 0.89
Protein chemical characterization of Gc globulin (vitamin D-binding protein) isoforms; Gc-1f, Gc-1s and Gc-2. Biochim Biophys Acta (2007) 0.89
Mass spectrometry analysis of the oligomeric C1q protein reveals the B chain as the target of trypsin cleavage and interaction with fucoidan. Biochemistry (2005) 0.88
Human and pneumococcal cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) proteins are both ligands of human C1q protein. J Biol Chem (2012) 0.88
Levamisole inhibits angiogenesis in vitro and tumor growth in vivo. Angiogenesis (2005) 0.88
The lectin-like activity of human C1q and its implication in DNA and apoptotic cell recognition. FEBS Lett (2008) 0.87
Structure and properties of the Ca(2+)-binding CUB domain, a widespread ligand-recognition unit involved in major biological functions. Biochem J (2011) 0.87
Analysis of human C1q by combined bottom-up and top-down mass spectrometry: detailed mapping of post-translational modifications and insights into the C1r/C1s binding sites. Mol Cell Proteomics (2009) 0.87
Deciphering complement receptor type 1 interactions with recognition proteins of the lectin complement pathway. J Immunol (2013) 0.87
Complement protein C1q forms a complex with cytotoxic prion protein oligomers. J Biol Chem (2010) 0.86
Complement protein C1q recognizes enzymatically modified low-density lipoprotein through unesterified fatty acids generated by cholesterol esterase. Biochemistry (2010) 0.85
Small angle X-ray scattering study of calreticulin reveals conformational plasticity. Biochim Biophys Acta (2008) 0.85
Influence of angiogenesis inhibitors on endothelial cell morphology in vitro. APMIS (2006) 0.85
Direct interaction between CD91 and C1q. FEBS J (2010) 0.85
Trimeric reassembly of the globular domain of human C1q. Biochim Biophys Acta (2007) 0.85